Biotech · Private company
CathVision ApS
Track this companyFree. Adds CathVision ApS to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- AF Recurrence RIsk Assessment post pulmonary vein isolationAtrial Fibrillation (AF)ClinicalTrials.gov · fetched Nov 12, 2026
- Cardiac Ablation for the treatment of persistent Atrial FibrillationPersistent Atrial FibrillationClinicalTrials.gov · fetched Nov 12, 2026
- Electrophysiology procedureCardiac ArrhythmiaClinicalTrials.gov · fetched Nov 12, 2026
- Pulmonary vein isolation ablationAtrial FibrillationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFARECRUITING · started Jul 22, 2026ClinicalTrials.gov NCT07275151 · fetched Nov 12, 2026
- P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein IsolationACTIVE_NOT_RECRUITING · started Apr 13, 2026ClinicalTrials.gov NCT07471308 · fetched Nov 12, 2026
- Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact AlgorithmCOMPLETED · started Jul 28, 2022ClinicalTrials.gov NCT05458648 · fetched Nov 12, 2026
- An Evaluation of the Safety and Performance of the CathVision ECGenius® System.COMPLETED · started Mar 29, 2022ClinicalTrials.gov NCT05301803 · fetched Nov 12, 2026